Search results for "Prostate Cancer"
Information plus documentation a must for informed consent
Documentation of informed consent is an important deterrent to malpractice and negligence claims. One physician describes how his informed consent process was the deciding factor in a missed case of prostate cancer, and outlines how any physician can accomplish it.
https://immattersacp.org/archives/2012/01/consent.htm
1 Jan 2012
Too much or too little selenium associated with higher mortality
Selenium supplements are beneficial to people with low levels of the mineral, but those with levels over 122 µg/L do not obtain improvement in mortality or other outcomes from supplementation, according to a new review of available studies on selenium.
https://immattersacp.org/weekly/archives/2012/03/06/5.htm
6 Mar 2012
European study finds prostate cancer mortality reduced by PSA screening
Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
https://immattersacp.org/weekly/archives/2012/03/20/4.htm
20 Mar 2012
USPSTF recommends against prostate-specific antigen screening
The U.S. Preventive Services Task Force (USPSTF) released its final recommendations on prostate-specific antigen (PSA) screening today, recommending against using the test for prostate cancer screening in men of all ages in the general population.
https://immattersacp.org/weekly/archives/2012/05/22/1.htm
22 May 2012
Tailor prostate screening based on life expectancy, ASCO recommends
A provisional clinical opinion from the American Society of Clinical Oncology (ASCO) recommends against prostate-specific antigen screening for men with a life expectancy of 10 years or less.
https://immattersacp.org/weekly/archives/2012/07/24/2.htm
24 Jul 2012
Metastatic disease reduced in PSA screening era, study indicates
Prostate-specific antigen (PSA) screening reduced the number of men presenting with metastatic prostate cancer, a new study found.
https://immattersacp.org/weekly/archives/2012/08/07/2.htm
7 Aug 2012
Benefit of PSA screening diminished in an analysis of ERSPC data using QALYs
A new analysis quantified the effects of prostate-specific antigen (PSA) screening on men's quality of life.
https://immattersacp.org/weekly/archives/2012/08/21/4.htm
21 Aug 2012
Generic pioglitazone, new HIV combination pill approved
This regulatory update covers approvals of the first generic form of pioglitazone and a combination form of emtricitabine, tonofavir and two new drugs for patients new to HIV treatment.
https://immattersacp.org/archives/2012/11/fda.htm
1 Nov 2012
Taking a drink: what patients should know
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013
Heparin labeling changed, non-egg flu vaccine approved
This regulatory update covers changed labeling for heparin and approval of a flu vaccine produced using cultured animal cells.
https://immattersacp.org/archives/2013/02/fda.htm
1 Feb 2013